Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blomia tropicalis allergen extract in house dust mite allergy
2011-003634-14Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Jan 2012
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of blomia tropicalis allergen extract in house dust mite allergy, sponsored by LETI Pharma. Started Jan 2012; status: completed.
02
Drugs
blomia tropicalis allergen extract
03
Conditions
house dust mite allergy
Beyond the preview
Go deeper on 2011-003634-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003634-14.